Quantitative MRI-based decision model for early-stage parkinsonism diagnosis: a pilot feasibility study.
| Title: | Quantitative MRI-based decision model for early-stage parkinsonism diagnosis: a pilot feasibility study. |
|---|---|
| Authors: | Nunez-Gonzalez L; Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, the Netherlands.; Dopper EGP; Department of Neurology, Erasmus MC, the Netherlands.; Alzheimer Centre, Erasmus MC, Rotterdam, the Netherlands.; van der Eerden AW; Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, the Netherlands.; Seada SA; Surgical Reality, Amsterdam, the Netherlands.; Boon AJW; Department of Neurology, Erasmus MC, the Netherlands.; Verbeek MM; Department of Neurology, Radboud University Medical Center, Nijmegen, the Netherlands.; Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.; Bloem BR; Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.; Anton Meijer FJ; Department of Medical Imaging, Radboud University Medical Center, Nijmegen, the Netherlands.; Hernandez-Tamames JA; Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, the Netherlands.; Department of Imaging Physics, TU Delft, the Netherlands. |
| Source: | Neuroimage. Reports [Neuroimage Rep] 2025 Jun 14; Vol. 5 (3), pp. 100273. Date of Electronic Publication: 2025 Jun 14 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Language: | English |
| Journal Info: | Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 9918227365206676 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-9560 (Electronic) Linking ISSN: 26669560 NLM ISO Abbreviation: Neuroimage Rep Subsets: PubMed not MEDLINE |
| Imprint Name(s): | Original Publication: Amsterdam : Elsevier B.V., [2021]- |
| Competing Interests: | Prof. Bloem serves as the co-Editor in Chief for the Journal of Parkinson's disease, serves on the editorial board of Practical Neurology and Digital Biomarkers, has received fees from serving on the scientific advisory board for the Critical Path Institute, Gyenno Science, MedRhythms, UCB, Kyowa Kirin and Zambon (paid to the Institute), has received fees for speaking at conferences from AbbVie, Bial, Biogen, GE Healthcare, Oruen, Roche, UCB and Zambon (paid to the Institute), and has received research support from 10.13039/100005614Biogen, Cure Parkinson's, 10.13039/100009862Davis Phinney Foundation, Edmond J. Safra Foundation, Fred Foundation, Gatsby Foundation, Hersenstichting Nederland, Horizon 2020, IRLAB Therapeutics, Maag Lever Darm Stichting, Michael J Fox Foundation, Ministry of Agriculture, Ministry of Economic Affairs & Climate Policy, Ministry of Health, Welfare and Sport, Netherlands Organization for Scientific Research (ZonMw), Not Impossible, Parkinson Vereniging, Parkinson's Foundation, Parkinson's UK, Stichting Alkemade-Keuls, Stichting Parkinson NL, Stichting Woelse Waard, Health Holland/Topsector Life Sciences and Health, UCB, Verily Life Sciences, Roche and Zambon. The other authors don't declare any conflict of interest. |
| References: | J Mov Disord. 2020 Jan;13(1):39-46. (PMID: 31552724); Neurology. 2013 May 14;80(20):1856-61. (PMID: 23616165); Front Neurol. 2020 May 28;11:366. (PMID: 32547468); AJNR Am J Neuroradiol. 2017 May;38(5):966-972. (PMID: 28364007); Lancet. 2021 Jun 12;397(10291):2284-2303. (PMID: 33848468); AJNR Am J Neuroradiol. 2015 Dec;36(12):2227-34. (PMID: 26338919); J Mov Disord. 2009 Oct;2(2):64-8. (PMID: 24868359); Parkinsonism Relat Disord. 2014 Aug;20(8):840-4. (PMID: 24816002); Neuroimage Clin. 2023;39:103506. (PMID: 37696098); Radiology. 2021 Aug;300(2):260-278. (PMID: 34100679); Mov Disord. 2017 Apr;32(4):510-525. (PMID: 28370449); Mov Disord. 2017 Jun;32(6):853-864. (PMID: 28467028); Mov Disord. 2013 Nov;28(13):1816-22. (PMID: 23674400); Mov Disord. 2020 Jan;35(1):161-170. (PMID: 31710146); J Psychiatr Res. 1975 Nov;12(3):189-98. (PMID: 1202204); PLoS One. 2014 Nov 18;9(11):e112638. (PMID: 25405990); Radiology. 2008 Jan;246(1):214-21. (PMID: 17991785); Neuroimage. 2021 Apr 15;230:117810. (PMID: 33524572); Tzu Chi Med J. 2021 Jan 19;34(2):169-181. (PMID: 35465274); Lancet. 2024 May 18;403(10440):2259-2262. (PMID: 38762327); J Neural Transm (Vienna). 2017 Aug;124(8):915-964. (PMID: 28378231); Front Neurol. 2020 Jul 17;11:665. (PMID: 32765399); Front Neurol. 2019 Feb 12;10:100. (PMID: 30809189); Parkinsonism Relat Disord. 2018 Sep;54:3-8. (PMID: 30068492); Radiology. 2006 Jun;239(3):825-30. (PMID: 16714464); Curr Treat Options Neurol. 2024 Jul;26(7):319-338. (PMID: 39886562); Neuroimage Clin. 2019;24:101999. (PMID: 31539801); Pol J Radiol. 2016 Aug 03;81:363-9. (PMID: 27559425); Res Q Exerc Sport. 1997 Mar;68(1):44-55. (PMID: 9094762); Neuroradiology. 2010 Dec;52(12):1087-94. (PMID: 20358367); Hum Brain Mapp. 2021 Oct 15;42(15):4809-4822. (PMID: 34322940); BMC Neurol. 2018 May 16;18(1):69. (PMID: 29764386); Parkinsonism Relat Disord. 2014 Jul;20(7):755-60. (PMID: 24768616); AJNR Am J Neuroradiol. 2015 Mar;36(3):454-60. (PMID: 25339647); Neurology. 2024 Dec 10;103(11):e210021. (PMID: 39531604); Mov Disord. 2022 Jun;37(6):1131-1148. (PMID: 35445419); Mov Disord. 2008 Nov 15;23(15):2129-70. (PMID: 19025984); Parkinsonism Relat Disord. 2020 Aug;77:57-63. (PMID: 32622301); Neuroimage. 2012 Aug 15;62(2):782-90. (PMID: 21979382); Mov Disord. 2015 Oct;30(12):1591-601. (PMID: 26474316); Hum Brain Mapp. 2019 Dec 1;40(17):4952-4964. (PMID: 31403237); Brain. 2002 Apr;125(Pt 4):861-70. (PMID: 11912118); Mov Disord. 2024 Sep;39(9):1514-1522. (PMID: 38847384); Mov Disord. 2017 May;32(5):778-782. (PMID: 28150443); Mov Disord. 2008 Dec 15;23(16):2370-6. (PMID: 18816803); Orphanet J Rare Dis. 2024 May 23;19(1):215. (PMID: 38778404); Neuroimage. 2015 Jun;113:184-95. (PMID: 25776214); Korean J Radiol. 2018 Jul-Aug;19(4):777-782. (PMID: 29962884); J Magn Reson Imaging. 2017 Oct;46(4):951-971. (PMID: 28295954); Neurology. 2005 Jun 28;64(12):2050-5. (PMID: 15985570); Brain. 2016 Feb;139(Pt 2):495-508. (PMID: 26705348); Parkinsonism Relat Disord. 2018 Jan;46:47-55. (PMID: 29126761); Parkinsonism Relat Disord. 2017 Nov;44:51-57. (PMID: 28886909) |
| Entry Date(s): | Date Created: 20251006 Date Completed: 20251006 Latest Revision: 20251008 |
| Update Code: | 20260130 |
| PubMed Central ID: | PMC12489762 |
| DOI: | 10.1016/j.ynirp.2025.100273 |
| PMID: | 41050949 |
| Database: | MEDLINE |
Journal Article